Unilever rules out big acquisitions after failed £50bn GSK consumer bid

The consumer giant also signalled that customers will continue to face higher prices amid efforts to control spiralling costs.

10 February 2022

Unilever has ruled out any big acquisitions in the near future following its failed £50 billion takeover of GlaxoSmithKline’s consumer arm as the Dove soap-maker warned it will be dented by soaring inflation.

The consumer giant, which makes products ranging from Marmite to Ben & Jerry’s ice cream, signalled that customers will continue to face higher prices as it seeks to keep a lid on rocketing costs.

It came during Unilever’s first update to the market after its tilt to snap up GSK’s consumer business – which includes brands such as Sensodyne and Panadol – was rejected by the pharmaceutical giant and heavily criticised by investors.

The FTSE 100 company had already been under fierce criticism days before the failed takeover move was announced, after Fundsmith founder and major investor Terry Smith accused the business of prioritising sustainability over financial performance.

On Thursday, Unilever said it has spoken in depth with its shareholders about the move and “now recognises there is not appetite for the deal or anything similar”.

It confirmed that it will focus on its portfolio of current products, growing the business organically and with smaller “bolt-on” acquisitions.

Group chief executive Alan Jope said: “We have engaged extensively with our shareholders in recent weeks and received a strong message that the evolution of our portfolio needs to be measured.

“We therefore do not intend to pursue major acquisitions in the foreseeable future and will conduct a share buyback programme of up to 3 billion euros (£2.53 billion) over the next two years.”

Unilever also told shareholders it expects to be hit by 2 billion euros (£1.7 billion) of cost inflation over the first half of 2022.

Chief financial officer Graeme Pitkethly said the business has been heavily affected by increases in freight costs, as well as surges in the cost of oils used in its products, such as a 130% rise in the price of palm oil.

The group reported a 4.5% jump in sales for 2021 as it was boosted by higher prices.

Unilever said this was driven by a 2.9% increase in prices, with the remaining 1.6% resulting from higher volumes as the group witnessed strong sales across its food business, with brands like Magnum and Ben & Jerry’s performing particularly strongly.

The company said it predicts an increase in sales to between 4.5% and 6.5% in 2022 as it seeks to push through further price rises in an effort to offset cost inflation.

Nevertheless, Unilever also reduced its profit margin guidance for the year, causing shares to drop as the markets opened on Thursday.

More from Perspective

Get a free copy of our print edition


Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Your email address will not be published. The views expressed in the comments below are not those of Perspective. We encourage healthy debate, but racist, misogynistic, homophobic and other types of hateful comments will not be published.